Press Releases

Patients at Medison’s network of clinics will gain access to next generation treatments and therapies by being matched to leading-edge, international clinical trials. This will also accelerate the launch of new treatments and medications in Georgia. The Medison network of...

Producing pharmaceutical products for the global market is hugely challenging and complex. When a drug is set to be sold in multiple countries, it needs to be packaged in a way which accommodates the regulatory requirements and specific artwork demands...

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for use in humans. The...

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to...

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma. Under the clinical trial collaboration agreement, GSK will sponsor and conduct an adaptive Phase...

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional antibody screening programme and to strengthen its own pipeline of preclinical functional...

AbbVie , a research-based global biopharmaceutical company announced that the U.S. FDA  has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase 3 trial evaluating venetoclax (VENCLEXTA® OR VENCLYXTO®) for the investigational treatment of relapsed/refractory multiple myeloma....